Gabriella Szűcs

5.5k total citations
122 papers, 3.1k citations indexed

About

Gabriella Szűcs is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Gabriella Szűcs has authored 122 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Rheumatology, 50 papers in Pathology and Forensic Medicine and 23 papers in Immunology. Recurrent topics in Gabriella Szűcs's work include Systemic Sclerosis and Related Diseases (46 papers), Systemic Lupus Erythematosus Research (34 papers) and Rheumatoid Arthritis Research and Therapies (31 papers). Gabriella Szűcs is often cited by papers focused on Systemic Sclerosis and Related Diseases (46 papers), Systemic Lupus Erythematosus Research (34 papers) and Rheumatoid Arthritis Research and Therapies (31 papers). Gabriella Szűcs collaborates with scholars based in Hungary, Israel and Norway. Gabriella Szűcs's co-authors include Zoltán Szekanecz, Szilvia Szamosi, Sándor Szántó, Katalin Dankó, Yehuda Shoenfeld, Emese Kiss, Péter Szodoray, Gyula Szegedi, Pál Soltész and Howard Amital and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Gabriella Szűcs

114 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriella Szűcs Hungary 30 1.2k 1.2k 772 426 413 122 3.1k
S Todesco Italy 32 2.0k 1.7× 997 0.9× 1.0k 1.3× 485 1.1× 310 0.8× 133 3.7k
Gyula Szegedi Hungary 30 1.4k 1.1× 657 0.6× 873 1.1× 492 1.2× 362 0.9× 96 2.6k
Paola Caramaschi Italy 31 909 0.8× 1.4k 1.2× 615 0.8× 410 1.0× 314 0.8× 144 2.9k
Emese Kiss Hungary 34 2.0k 1.6× 888 0.8× 1.2k 1.6× 379 0.9× 352 0.9× 130 3.2k
Alberto Moggi Pignone Italy 30 548 0.5× 1.4k 1.2× 522 0.7× 335 0.8× 551 1.3× 127 2.7k
Theodoros Dimitroulas Greece 28 971 0.8× 727 0.6× 413 0.5× 313 0.7× 303 0.7× 173 2.6k
Maureen Rischmueller Australia 31 1.0k 0.9× 612 0.5× 902 1.2× 262 0.6× 313 0.8× 89 2.8k
Vasiliki Liakouli Italy 34 645 0.5× 867 0.7× 868 1.1× 268 0.6× 852 2.1× 90 3.0k
John Sibley Canada 20 1.7k 1.4× 724 0.6× 528 0.7× 235 0.6× 284 0.7× 37 2.8k
Kevin G. Moder United States 26 1.3k 1.1× 715 0.6× 560 0.7× 265 0.6× 236 0.6× 64 2.5k

Countries citing papers authored by Gabriella Szűcs

Since Specialization
Citations

This map shows the geographic impact of Gabriella Szűcs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriella Szűcs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriella Szűcs more than expected).

Fields of papers citing papers by Gabriella Szűcs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriella Szűcs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriella Szűcs. The network helps show where Gabriella Szűcs may publish in the future.

Co-authorship network of co-authors of Gabriella Szűcs

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriella Szűcs. A scholar is included among the top collaborators of Gabriella Szűcs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriella Szűcs. Gabriella Szűcs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagy, Gábor, Tamás Juhász, Gabriella Szűcs, et al.. (2025). Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: Insights into Fibrosis and Autoimmunity for Translational Research. International Journal of Molecular Sciences. 26(6). 2618–2618. 1 indexed citations
2.
Szűcs, Gabriella, et al.. (2025). Malignancy in Systemic Sclerosis: A Multicenter Retrospective Study. Biomedicines. 13(4). 993–993. 1 indexed citations
3.
Ciaffi, Jacopo, Suzanne C. Cannegieter, Eva M. Hoekstra, et al.. (2024). Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD Open. 10(2). e004101–e004101. 3 indexed citations
4.
Simon, Diána, Boglárka Soós, Edit Végh, et al.. (2024). Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology. International Journal of Molecular Sciences. 25(6). 3429–3429. 1 indexed citations
5.
Szegedi, Andrea, Dániel Törőcsik, József Varga, et al.. (2023). Psoriatic arthritis and its special features predispose not only for osteoporosis but also for fractures and falls. The Journal of Dermatology. 50(5). 608–614. 2 indexed citations
6.
Szekanecz, Zoltán, Gabriella Szűcs, & György Kerekes. (2023). Antirheumatic drugs and cardiovascular disease in rheumatoid arthritis. 9(2). 49–62. 1 indexed citations
7.
8.
Nagy‐Vincze, Melinda, Zoltán Griger, Katalin Dankó, et al.. (2023). Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases. Autoimmunity Reviews. 22(5). 103311–103311. 3 indexed citations
9.
Atzeni, Fabiola, Javier Rodríguez‐Carrio, Călin D. Popa, et al.. (2021). Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis. Nature Reviews Rheumatology. 17(5). 306–306. 3 indexed citations
10.
Végh, Edit, Ágnes Horváth, Attila Hamar, et al.. (2021). Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules. 11(10). 1535–1535. 10 indexed citations
11.
Balla, József, et al.. (2020). P0212IMMUNOSUPPRESSIVE TREATMENT OF PATIENTS WITH ANCA ASSOCIATED VASCULITIS (AAV) IN CHRONIC DIALYSIS PROGRAM. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
12.
Szekanecz, Zoltán, Boglárka Soós, Levente Bodoki, et al.. (2020). Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. Autoimmunity Reviews. 19(11). 102658–102658. 14 indexed citations
13.
Póliska, Szilárd, Tímea Besenyei, Edit Végh, et al.. (2019). Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 94–94. 9 indexed citations
14.
Végh, Edit, Péter Csomor, Szilvia Szamosi, et al.. (2016). Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept. Joint Bone Spine. 83(6). 675–679. 31 indexed citations
15.
Hársfalvi, Jolán, András Berta, Krisztina Köröskényi, et al.. (2015). Vascular Endothelial Growth Factor in Tear Samples of Patientswith Systemic Sclerosis. Mediators of Inflammation. 2015(1). 573681–573681. 21 indexed citations
16.
Szekanecz, Zoltán, Edit Végh, Andrea Váncsa, et al.. (2012). Vascular rheumatology: atherosclerosis and cardiovascular disease in arthritis. Reumatologia/Rheumatology. 50(4). 336–344. 1 indexed citations
17.
Szilasi, Mária, János Mátyus, Gabriella Szűcs, et al.. (2012). Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: Rituximab may be the right choice?. Autoimmunity. 45(4). 304–309. 14 indexed citations
18.
Zandman‐Goddard, Gisele, Hedi Orbach, Nancy Agmon‐Levin, et al.. (2011). Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients. Clinical Reviews in Allergy & Immunology. 44(1). 23–30. 34 indexed citations
19.
Szűcs, Gabriella, et al.. (1994). Correlations of Monocyte Phagocytic Receptor Expressions with Serum Immune Complex Level in Systemic Lupus Erythematosus. Scandinavian Journal of Immunology. 40(5). 481–484. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Todesco Breakdown of academic impact, for papers by Gyula Szegedi Breakdown of academic impact, for papers by Paola Caramaschi Breakdown of academic impact, for papers by Emese Kiss Breakdown of academic impact, for papers by Alberto Moggi Pignone Breakdown of academic impact, for papers by Theodoros Dimitroulas Breakdown of academic impact, for papers by Maureen Rischmueller Breakdown of academic impact, for papers by Vasiliki Liakouli Breakdown of academic impact, for papers by John Sibley Breakdown of academic impact, for papers by Kevin G. Moder
Rankless by CCL
2026